New Onset of Tuberculosis Complicating FDG PET/CT Evaluation in Patient with Recent Chimeric Antigen Receptor T-Cell Therapy

Guanyun Wang,Xu Yang,Hongrong Wang,Wei Wang,Jigang Yang
DOI: https://doi.org/10.1097/rlu.0000000000004655
IF: 10.6
2023-01-01
Clinical Nuclear Medicine
Abstract:A 16-year-old adolescent girl with CD19 chimeric antigen receptor (CAR) T-cell therapy for acute lymphoblastic leukemia experienced new onset of the fever. 18 F-FDG PET/CT studies acquired at 1 and 2 months, respectively, after CAR-T, showed foci of abnormal activity in the mediastinal lymph nodes not seen on the study before therapy. However, these foci of abnormal activity were later proven due to newly developed tuberculosis after CAR T-cell therapy.
What problem does this paper attempt to address?